| Author | Title | Source | Year |
| Wei CT, Chen LC, Hsiang YP, Hung YJ, Chien PH, Pan HL, Chen YJ. | Chrysin-induced ERK1/2 Phosphorylation Enhances the Sensitivity of Human Hepatocellular Carcinoma Cells to Sorafenib. | Anticancer Res. 2019 Feb;39(2):695-701. doi: 10.21873/anticanres.13165. | 2019 |
| Chen JY, Huang WC, Wei CT, Chien PH, Chen YJ. | The C-Terminus of Hepatitis B Virus-encoded X Protein Is Required for Lapatinib Sensitivity in Hepatocellular Carcinoma Cells. | Anticancer Res. 2019 Feb;39(2):721-726. doi: 10.21873/anticanres.13168. | 2019 |
| Lin YM, Chen CI, Hsiang YP, Hsu YC, Cheng KC, Chien PH, Pan HL, Lu CC, Chen YJ. | Chrysin Attenuates Cell Viability of Human Colorectal Cancer Cells through Autophagy Induction Unlike 5-Fluorouracil/Oxaliplatin. | Int J Mol Sci. 2018 Jun 14;19(6). pii: E1763. doi: 10.3390/ijms19061763. | 2018 |
| Huang WC, Hung CM, Wei CT, Chen TM, Chien PH, Pan HL, Lin YM, Chen YJ. | Interleukin-6 expression contributes to lapatinib resistance through maintenance of stemness property in HER2-positive breast cancer cells. | Oncotarget. 2016 Sep 20;7(38):62352-62363. doi: 10.18632/oncotarget.11471. | 2016 |
| Wu SJ, Chen YJ, Shieh TY, Chen CM, Wang YY, Lee KT, Lin YM, Chien PH, Chen PH. | Association study between novel CYP26 polymorphisms and the risk of betel quid-related malignant oral disorders. | ScientificWorldJournal. 2015;2015:160185. doi: 10.1155/2015/160185. Epub 2015 Mar 9. | 2015 |
| Wu SJ, Chen YJ, Shieh TY, Chen CM, Wang YY, Lee KT, Lin YM, Chien PH, Chen PH. | Association Study between Novel CYP26 Polymorphisms and the Risk of Betel Quid-Related Malignant Oral Disorders. | ScientificWorldJournal. 2015;2015:160185. doi: 10.1155/2015/160185. Epub 2015 Mar 9. | 2015 |
| Chen YJ, Yeh MH, Yu MC, Wei YL, Chen WS, Chen JY, Shih CY, Tu CY, Chen CH, Hsia TC, Chien PH, Liu SH, Yu YL, Huang WC. | Lapatinib--induced NF-kappaB activation sensitizes triple-negative breast cancer cells to proteasome inhibitors. | Breast Cancer Res. 2013 Nov 12;15(6):R108. [Epub ahead of print] | 2013 |
| Huang WC, Hsieh YL, Hung CM, Chien PH, Chien YF, Chen LC, Tu CY, Chen CH, Hsu SC, Lin YM, Chen YJ. | BCRP/ABCG2 Inhibition Sensitizes Hepatocellular Carcinoma Cells to Sorafenib. | PLoS One. 2013 Dec 31;8(12):e83627. | 2013 |